NCT02176460View on ClinicalTrials.gov

Colchicine for Symptom and Inflammation in Knee Osteoarthritis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Knee Osteoarthritis

Interventions

DRUG

Colchicine

0.5mg twice daily for 16 weeks

DRUG

Placebo

1 tablet twice daily

Trial Locations (1)

169608

Singapore General Hospital, Singapore

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Singapore General Hospital

OTHER